DK0768867T3 - Doseringsform til indgivelse af lægemiddel i væskeformig formulering - Google Patents

Doseringsform til indgivelse af lægemiddel i væskeformig formulering

Info

Publication number: DK0768867T3
Authority: DK; Denmark
Prior art keywords: dosage form; drug; administration; liquid formulation; disclosed
Prior art date: 1994-06-13

Application number

DK94920203T

Other languages

Danish (da)

English (en)

Inventor

Steven D Larsen

George V Guittard

Patrick S-L Wong

Original Assignee

Alza Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-13

Filing date

1994-06-13

Publication date

2002-10-28

1994-06-13 Application filed by Alza Corp filed Critical Alza Corp

2002-10-28 Application granted granted Critical

2002-10-28 Publication of DK0768867T3 publication Critical patent/DK0768867T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

Health & Medical Sciences (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK94920203T 1994-06-13 1994-06-13 Doseringsform til indgivelse af lægemiddel i væskeformig formulering DK0768867T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1994/006723 WO1995034285A1 (en)	1994-06-13	1994-06-13	Dosage form for administering drug in liquid formulation

Publications (1)

Publication Number	Publication Date
DK0768867T3 true DK0768867T3 (da)	2002-10-28

Family

ID=22242671

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94920203T DK0768867T3 (da)	1994-06-13	1994-06-13	Doseringsform til indgivelse af lægemiddel i væskeformig formulering

Country Status (11)

Country	Link
EP (1)	EP0768867B1 (pt)
JP (1)	JP3901727B2 (pt)
KR (1)	KR100360636B1 (pt)
AT (1)	ATE225647T1 (pt)
AU (1)	AU682703B2 (pt)
CA (1)	CA2185119C (pt)
DE (1)	DE69431533T2 (pt)
DK (1)	DK0768867T3 (pt)
ES (1)	ES2183841T3 (pt)
PT (1)	PT768867E (pt)
WO (1)	WO1995034285A1 (pt)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5904935A (en) *	1995-06-07	1999-05-18	Alza Corporation	Peptide/protein suspending formulations
CA2306448A1 (en)	1997-10-16	1999-04-22	Board Of Regents, The University Of Texas System	Models and treatments for cardiac hypertrophy in relation with nf-at3 function
HU226669B1 (en) *	1998-09-09	2009-06-29	Alza Corp	Dosage form comprising liquid formulation
PT1140012E (pt) *	1998-12-17	2004-05-31	Alza Corp	Conversao de capsulas de gelatina cheias com liquido em sistemas de libertacao controlada por camadas multiplas
US7258869B1 (en)	1999-02-08	2007-08-21	Alza Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7919109B2 (en)	1999-02-08	2011-04-05	Intarcia Therapeutics, Inc.	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
UY28056A1 (es) *	2002-10-31	2003-12-31	Alza Corp	Formas de dosificacion que proporcionan la liberacion ascendente de una formulacion liquida.
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US8246986B2 (en)	2003-09-26	2012-08-21	Alza Corporation	Drug coating providing high drug loading
US8541026B2 (en)	2004-09-24	2013-09-24	Abbvie Inc.	Sustained release formulations of opioid and nonopioid analgesics
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
DE602007009377D1 (de)	2006-05-30	2010-11-04	Intarcia Therapeutics Inc	Zweiteiliger flussmodulator mit einem internen kanal für ein osmotisches ausgabesystem
EP2359808B1 (en)	2006-08-09	2013-05-22	Intarcia Therapeutics, Inc	Osmotic delivery systems and piston assemblies
AU2008244523B2 (en)	2007-04-23	2012-02-16	Intarcia Therapeutics, Inc.	Suspension formulations of insulinotropic peptides and uses thereof
EP2170283B1 (en)	2007-06-22	2019-01-09	Board of Regents, The University of Texas System	Formation of stable submicron peptide or protein particles by thin film freezing
DK2240155T3 (da)	2008-02-13	2012-09-17	Intarcia Therapeutics Inc	Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
US8779094B2 (en)	2008-11-16	2014-07-15	Board Of Regents, The University Of Texas System	Low viscosity highly concentrated suspensions
LT2462246T (lt)	2009-09-28	2017-11-27	Intarcia Therapeutics, Inc	Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
TWI615155B (zh) *	2011-11-01	2018-02-21	拜耳股份有限公司	滲透活性的陰道遞送系統
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US10925639B2 (en)	2015-06-03	2021-02-23	Intarcia Therapeutics, Inc.	Implant placement and removal systems
EP3458084B1 (en)	2016-05-16	2020-04-01	Intarcia Therapeutics, Inc	Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
KR20190104039A (ko)	2017-01-03	2019-09-05	인타르시아 세라퓨틱스 인코포레이티드	Glp-1 수용체 효능제의 연속적인 투여 및 약물의 동시-투여를 포함하는 방법
JP7195345B2 (ja)	2018-03-05	2022-12-23	アムニールコンプレックスプロダクツリサーチエルエルシー	薬物の時間放出のためのプログラム可能な医薬組成物
USD933219S1 (en)	2018-07-13	2021-10-12	Intarcia Therapeutics, Inc.	Implant removal tool and assembly
WO2020181127A1 (en)	2019-03-05	2020-09-10	Kashiv Biosciences, Llc	Delayed release methylphenidate compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4814180A (en) *	1984-03-21	1989-03-21	Alza Corporation	Agent dispenser comprising a semipermeable wall surrounding single-piece or two-piece container
GB2155889B (en) *	1984-03-21	1988-03-02	Alza Corp	Dispenser-capsule
US5324280A (en) *	1990-04-02	1994-06-28	Alza Corporation	Osmotic dosage system for delivering a formulation comprising liquid carrier and drug

1994
- 1994-06-13 DE DE69431533T patent/DE69431533T2/de not_active Expired - Fee Related
- 1994-06-13 EP EP94920203A patent/EP0768867B1/en not_active Expired - Lifetime
- 1994-06-13 AT AT94920203T patent/ATE225647T1/de not_active IP Right Cessation
- 1994-06-13 DK DK94920203T patent/DK0768867T3/da active
- 1994-06-13 CA CA002185119A patent/CA2185119C/en not_active Expired - Fee Related
- 1994-06-13 WO PCT/US1994/006723 patent/WO1995034285A1/en active IP Right Grant
- 1994-06-13 AU AU71080/94A patent/AU682703B2/en not_active Ceased
- 1994-06-13 PT PT94920203T patent/PT768867E/pt unknown
- 1994-06-13 KR KR1019960707046A patent/KR100360636B1/ko not_active IP Right Cessation
- 1994-06-13 ES ES94920203T patent/ES2183841T3/es not_active Expired - Lifetime
- 1994-06-13 JP JP50208996A patent/JP3901727B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
EP0768867A1 (en)	1997-04-23
JP3901727B2 (ja)	2007-04-04
EP0768867B1 (en)	2002-10-09
WO1995034285A1 (en)	1995-12-21
PT768867E (pt)	2003-01-31
DE69431533D1 (de)	2002-11-14
DE69431533T2 (de)	2003-10-02
CA2185119C (en)	2005-07-26
JPH10501261A (ja)	1998-02-03
KR970703752A (ko)	1997-08-09
AU682703B2 (en)	1997-10-16
ATE225647T1 (de)	2002-10-15
CA2185119A1 (en)	1995-12-21
KR100360636B1 (ko)	2002-12-18
AU7108094A (en)	1996-01-05
ES2183841T3 (es)	2003-04-01

Similar Documents

Publication	Publication Date	Title
DK0768867T3 (da)	2002-10-28	Doseringsform til indgivelse af lægemiddel i væskeformig formulering
DE69106501D1 (de)	1995-02-16	Osmotisches dosiersystem zur verabreichung von flüssigen arzneimitteln.
BG60102B2 (bg)	1993-10-29	Метод за получаване на 5-флуор-2(((4-циклопропил- метокси-2-пиридинил)метил)тионил)-1н-бензимидазол
DK135389A (da)	1989-09-22	Osmotisk indretning til administration af en terapeutisk effektiv maengde laegemiddel
ID25988A (id)	1994-11-10	FORMULASI OBAT YANG LARUTNYA BISA DIATUR (Pecahan dari P-940726)
ATE427103T1 (de)	2009-04-15	Orale verabreichung von adenosin analogen
DE69434626D1 (de)	2006-04-20	Transparente flüssigkeit zur verabreichung von verkapselten medikamenten
DK1006935T3 (da)	2005-06-06	Styret afgivelsessystem med en væske med höj viskositet
SE8505112D0 (sv)	1985-10-29	Novel pharmacological compounds
DE60019334D1 (de)	2005-05-12	Antivirale arznei
ES2125679T3 (es)	1999-03-01	Sistema transdermico de administracion simultanea de varios principios activos.
SE8305485L (sv)	1984-04-06	Galeniska kompositioner innefattande kalcitonin och deras anvendning
MY101784A (en)	1992-01-17	Novel pharmacological compounds
HUP9900751A2 (hu)	1999-07-28	Parathormontartalmú stabil gyógyászati készítmény
IT1170214B (it)	1987-06-03	Composizione farmaceutica per la cura delle arteriopatie periferiche
ATE311858T1 (de)	2005-12-15	Dosierungsform mit flüssiger formulierung
ES2126127T3 (es)	1999-03-16	Composicion farmaceutica liquida para uso oral, que contiene acido 2-(4-isobutilfenil)propionico.
SE8404065D0 (sv)	1984-08-10	Novel biologically active compounds
KR910009259A (ko)	1991-06-28	천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
ES2125354T3 (es)	1999-03-01	Composicion a base de tandospirona o de sus analogos.
MY102411A (en)	1992-06-17	Nasal solutions
PT627916E (pt)	2003-09-30	Composicao farmaceutica utilizavel como analgesico contendo o acido (r)-2-(3-benzoilfenil)propionico
DK464483A (da)	1984-04-09	Fremgangsmaade til fremstilling af et farmaceutisk praeparat indeholdende et fibrinolytisk middel
ATE205829T1 (de)	2001-10-15	Fibrinogen receptor antagonisten mit substituierten b-aminosäurenestern und diese enthaltende pharmazeutische präparate
HK1029277A1 (en)	2001-03-30	Pharmaceutical coating composition and method of use.